Skip to main content
. 2016 Jan 20;26(10):3428–3436. doi: 10.1007/s00330-015-4198-x

Fig. 3.

Fig. 3

Kaplan-Meier estimates of (a) OS between type I + II and III PVTT patients, (b) OS between the TACE-Iodine125 and TACE groups in type I + II PVTT patients, and (c) OS between the TACE-Iodine125 and TACE groups in type III PVTT patients